Skip to main content

Table 1 Relationship between NEIL3 expression and clinicopathology in the TCGA LUAD cohort

From: NEIL3 may act as a potential prognostic biomarker for lung adenocarcinoma

Characteristics n NEIL3 χ2 P value
Low expression High expression
Total 293 147 146   
Age 0.206 0.65
 ≤ 60 98 51 (52.05) 47 (47.95)   
 > 60 195 96 (49.24) 99 (50.76)   
Gender 2.13 0.144
 Male 138 63 (45.65) 75 (54.35)   
 Female 155 84 (54.19) 71 (45.81)   
TNM stage 7.689 0.004*
 I and II 223 122 (54.70) 101 (45.30)   
 III and IV 70 25 (35.70) 45 (64.30)   
Tumor stage 7.201 0.027*
 I 88 54 (61.40) 34 (38.60)   
 II 169 80 (47.30) 89 (52.70)   
 III and IV 37 14 (37.80) 23 (62.20)   
Metastasis stage 2.809 0.094
 Negative 274 141 (51.50) 133 (48.50)   
 Positive 19 6 (31.60) 13 (68.40)   
Node stage 2.259 0.133
 Negative 187 100 (53.50) 87 (46.50)   
 Positive 106 47 (44.30) 59 (55.70)   
  1. *Statistically significant